Journal Article

Psychiatric Barriers to Readiness for Treatment for Hepatitis C Virus (HCV) Infection among Injection Drug Users: Clinical Experience of an Addiction Psychiatrist in the HIV-HCV Coinfection Clinic of a Public Health Hospital

Harriet Scheft and Dominique C. Fontenette

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 40, issue Supplement_5, pages S292-S296
Published in print April 2005 | ISSN: 1058-4838
Published online April 2005 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/427443
Psychiatric Barriers to Readiness for Treatment for Hepatitis C Virus (HCV) Infection among Injection Drug Users: Clinical Experience of an Addiction Psychiatrist in the HIV-HCV Coinfection Clinic of a Public Health Hospital

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Among injection drug users, psychological and psychiatric barriers to readiness for treatment for hepatitis C virus (HCV) infection include mood and anxiety disorders, cognitive deficits, temperament disorders, and personality vulnerabilities, as well as ongoing drug use. Many aspects of these barriers can be overcome with direct treatment or social support. To establish effective treatment for HCV infection in this population of patients, it is essential that the patient and providers develop a rapport that allows for active communication. It is also important that the patient make an effort to adhere to the treatment requirements and that the patient receive the appropriate evaluation and management of treatable barriers.

Journal Article.  3070 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.